Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer.
Christine M Cramer-van der WelleFranz M N H SchramelArvid S van LeeuwenHarry J M GroenEwoudt M W van de Gardenull nullPublished in: European journal of cancer care (2020)
After first-line systemic treatment in ED SCLC the fraction of patients receiving subsequent lines of treatment is rapidly decreasing. This information is necessary as background for evaluation of the added value of future drugs under study for ED SCLC.